fbpx

Resources

Dec 20, 2024

A look at geographic atrophy in 2024: The highs, lows of treatment trials

By: Kate Young-Fact checked by: Heather Biele In 2024, Healio covered several stories about trials investigating geographic atrophy biomarkers and treatment options. While one trial found that intravitreal pegcetacoplan showed…

A look at geographic atrophy in 2024: The highs, lows of treatment trials

Dec 17, 2024

The Macular Degeneration Association Welcomes New Medical Board Member

The Macular Degeneration Association (MDA) is proud to welcome Jessica Cameron, OD, FAAO as one of our distinguished Medical Board members. Dr. Cameron is a low vision specialist. She owns…

The Macular Degeneration Association Welcomes New Medical Board Member

Dec 17, 2024

Press Release – EYLEA HD Phase 3 Trial results (QUASAR trial)

  Eylea HD injection of 8 gm in the Phase 3 trial (QUASAR trial) is meeting the primary endpoints showing improved vision with extended dosing intervals in patients with macular…

Press Release – EYLEA HD Phase 3 Trial results (QUASAR trial)

Dec 16, 2024

Galimedix Therapeutics initiates phase 1 trial of oral GAL-101

Author(s): David Hutton Key Takeaways GAL-101 targets misfolded amyloid beta monomers, preventing toxic oligomer and protofibril formation, with potential applications in Alzheimer’s, dry AMD, and glaucoma. The Phase 1 trial…

Galimedix Therapeutics initiates phase 1 trial of oral GAL-101

Dec 12, 2024

Exclusive 20% Off on Your Eye Care Essentials!

  As part of our ongoing commitment to your eye health, we wanted to alert you about our partnership with DryEye Rescue, a trusted provider of specialized eye care products.…

Exclusive 20% Off on Your Eye Care Essentials!

Dec 10, 2024

‘Not all chocolate is created equal’: New data imply the dark variety lowers diabetes risk

By: Andrew (Drew) Rhoades Fact checked by: Gina Brockenbrough, MA  Key takeaways: Eating 5 ounces or more of chocolate a week lowered type 2 diabetes risk. Results showed no link…

‘Not all chocolate is created equal’: New data imply the dark variety lowers diabetes risk

Dec 10, 2024

ARCHER trial shows benefit of ANX007 on vision loss in geographic atrophy

By: Michela Cimberle Fact checked by Christine Klimanskis, ELS BARCELONA, Spain — In the phase 2 ARCHER trial, ANX007, a novel C1q inhibitor with neuroprotective properties, showed consistent protection against loss of…

ARCHER trial shows benefit of ANX007 on vision loss in geographic atrophy

Dec 9, 2024

Is Nutrition The Culprit? With Dr. Poteet

A new video discusses nutrition and its affects on our bodies and our eyes. Did you know your nutrition can impact your risk of disease? Dr. Julie Poteet is a…

Is Nutrition The Culprit? With Dr. Poteet

Dec 3, 2024

Sun Pharma announces positive Phase 4 data results in dry eye disease

Author(s): David Hutton Key Takeaways Cyclosporine ophthalmic solution 0.09% significantly improves dry eye disease symptoms in patients inadequately controlled on Restasis. The Phase 4 study showed sustained improvements in corneal…

Sun Pharma announces positive Phase 4 data results in dry eye disease

Nov 27, 2024

Happy Thanksgiving

Happy Thanksgiving from our families to yours. We are grateful for your support and friendship. We will be closed on Thursday & Friday in observance of the Holiday.

Happy Thanksgiving

Nov 22, 2024

Adverum reports positive 52-week, 4-year data for wet AMD gene therapy

by: Alex Young & Anthony DeFino Adverum Biotechnologies reported positive 52-week data from the phase 2 LUNA trial as well as long-term follow-up results from the OPTIC trial of Ixo-vec…

Adverum reports positive 52-week, 4-year data for wet AMD gene therapy

Nov 22, 2024

Early positive data reported for geographic atrophy modifier gene therapy

Key takeaways: Low-dose OCU410 slowed lesion growth, preserved retinal tissue, and stabilized visual function in three patients. No drug-related serious adverse events were reported. OCU410, a single-dose modifier gene therapy,…

Early positive data reported for geographic atrophy modifier gene therapy

Nov 18, 2024

Understanding blue light: Making sense of the spectrum

By Thomas A. Wong, OD, FAAO, FNAP & Karl Citek, OD, PhD, FAAO A new classification system helps patients reach informed decisions.

Understanding blue light: Making sense of the spectrum

Nov 18, 2024

4 favorite foods with the most toxic plasticizers

By Anastasia Climan, RDN, CD-N | Fact-checked by Barbara Bekiesz | Published November 15, 2024 Key Takeaways The use of phthalates in food processing and packaging has led to widespread daily exposure, often in foods that are marketed…

4 favorite foods with the most toxic plasticizers

Nov 12, 2024

Pistachios take over carrots as ultimate weapon for better, sharper vision?

Scientists have found nutty substitute for people seeking to improve eye health but dislike carrot by: Web Desk November 11, 2024 Carrots are often hailed as a superfood for eye…

Pistachios take over carrots as ultimate weapon for better, sharper vision?

Nov 8, 2024

FDA grants de novo authorization to photobiomodulation device for dry AMD

Key takeaways: The light delivery system maintained vision in a trial among patients with dry age-related macular degeneration. It is the first authorized treatment for vision loss related to dry…

FDA grants de novo authorization to photobiomodulation device for dry AMD

Nov 7, 2024

Dropless cataract surgery: Shifting paradigm in postoperative care

Author(s): Monique M. Barbour, MD, Bria George, PharmD Key Takeaways Dropless cataract surgery eliminates postoperative eye drops, enhancing patient adherence and reducing complications like infection and inflammation. Intracameral drug delivery…

Dropless cataract surgery: Shifting paradigm in postoperative care

Nov 7, 2024

FDA clears investigational new drug application for wet AMD gene therapy

The FDA granted investigational drug clearance to HG202, a CRISPR/Cas13Y RNA-editing therapy for neovascular age-related macular degeneration, according to a press release from HuidaGene. According to the release, HG202 is the…

FDA clears investigational new drug application for wet AMD gene therapy

Nov 6, 2024

Intense pulsed light for treatment of dry eye disease

Author(s): David Hutton Joanne F. Shen, MD, director of the dry eye clinic at Mayo Clinic’s campus in Phoenix, Arizona, and a research team studied 35 patients treated with IPL/MGX.…

Intense pulsed light for treatment of dry eye disease

Nov 4, 2024

UV protection for the eyes: What patients need to know

October 29, 2024, By Cristina M. Schnider, OD, MSc, MBA, FAAO Many people know that invisible UV light can cause a sunburn and contribute to skin aging and skin cancer, but…

UV protection for the eyes: What patients need to know

Oct 29, 2024

Daily consumption of pistachios boosts macular pigment optical density in healthy adults

October 28, 2024 Key takeaways: Eating 2 oz. of pistachios daily for 12 weeks significantly increased macular pigment optical density. Serum lutein concentration also improved in the group that consumed…

Daily consumption of pistachios boosts macular pigment optical density in healthy adults

Oct 28, 2024

Genetic Links Explored: How inherited retinal dystrophies affect refractive errors in patients

Specific genes associated with inherited retinal dystrophies (IRDs) also influence refractive errors (RE), such as myopia and hyperopia, according to a study that found these genetic patterns vary widely, suggesting…

Genetic Links Explored: How inherited retinal dystrophies affect refractive errors in patients

Oct 28, 2024

Alkeus Pharmaceuticals announces topline results from SAGA trial on GA treatment

October 25, 2024 ew study about Geographic Atrophy  By Jordana Joy, Associate Editor The data showed a 15.3% reduction in the GA lesion growth rate versus placebo from 6 to 24…

Alkeus Pharmaceuticals announces topline results from SAGA trial on GA treatment

Oct 23, 2024

#GIVING TUESDAY 2024

SAVE THE DATE: Tuesday December 3rd, 2024 #GivingTuesday—a movement to create a global day of giving Today. We need your help to help those Living with Macular Degeneration On Tuesday,…

#GIVING TUESDAY 2024

Oct 22, 2024

Light therapy: Potential treatment for dry AMD

by: Lynda Charters Listen Key Takeaways Photobiomodulation may reduce visual loss and disease progression in dry AMD, offering a new treatment option for patients. The study showed significant visual acuity…

Light therapy: Potential treatment for dry AMD

Oct 7, 2024

Metformin Shows Promise for Treating Macular Degeneration in Mice

A new study shows metformin may help prevent vision loss associated with age-related macular degeneration. News Published: October 7, 2024 Original story from the University of Chicago Age-related macular degeneration…

Metformin Shows Promise for Treating Macular Degeneration in Mice

Sep 23, 2024

Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA

September 19, 2024 By David Hutton Oral gildeuretinol demonstrated a clinically meaningful reduction in the geographic atrophy lesion growth rate at 24 months, supporting additional clinical development. SAGA topline data has…

Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA

Sep 19, 2024

Eye Drop Company in FDA’s Sights Once Again

The agency sounds alarm that products still may contain amniotic fluid by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today September 17, 2024 The FDA has sent another letter — this…

Eye Drop Company in FDA’s Sights Once Again

Sep 16, 2024

These foods sabotage sleep

By Julia Ries | Fact-checked by Davi Sherman | Published September 13, 2024 Key Takeaways Certain foods like chocolate, greasy snacks, and spicy dishes can disrupt sleep due to their effects on digestion and caffeine content.…

These foods sabotage sleep

Sep 12, 2024

The Changing Landscape of Nutrition in Medicine

A look at developments that have propelled us forward and those still to come for eye care. by: Julie Poteet, OD, MS, CNS, FOWNS At A Glance The increasing prevalence…

The Changing Landscape of Nutrition in Medicine

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.